APA (7th ed.) Citation

Huebner, G., Link, H., Kohne, C. H., Stahl, M., Kretzschmar, A., Steinbach, S., . . . Group, G. C. S. (2009). Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: A randomised prospective phase II trial. British Journal of Cancer, 100(1), 44. https://doi.org/10.1038/sj.bjc.6604818

Chicago Style (17th ed.) Citation

Huebner, G., et al. "Paclitaxel and Carboplatin Vs Gemcitabine and Vinorelbine in Patients with Adeno- or Undifferentiated Carcinoma of Unknown Primary: A Randomised Prospective Phase II Trial." British Journal of Cancer 100, no. 1 (2009): 44. https://doi.org/10.1038/sj.bjc.6604818.

MLA (9th ed.) Citation

Huebner, G., et al. "Paclitaxel and Carboplatin Vs Gemcitabine and Vinorelbine in Patients with Adeno- or Undifferentiated Carcinoma of Unknown Primary: A Randomised Prospective Phase II Trial." British Journal of Cancer, vol. 100, no. 1, 2009, p. 44, https://doi.org/10.1038/sj.bjc.6604818.